| BCBS Highmark Penn Medicare Advantage | Cataract Extraction (including Complex Cataract Surgery) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Endovenous Stenting | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Upper Gastrointestinal Endoscopy (Diagnostic and Therapeutic) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Pertuzumab, trastuzumab, and hyaluronidase-zzxf (Phesgo) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Docetaxel (Taxotere) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Fulvestrant (Faslodex) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Teprotumumab-trbw (Tepezza) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Alemtuzumab (Lemtrada) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Ublituximab-xiiy (Briumvi) | 2025-10-01 |